 | | BPNUQXPIQBZCMR-LJQANCHMSA-N | 1 | 1 | 0 | 100% | active |
 | | WJEOLQLKVOPQFV-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | MPVGZUGXCQEXTM-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | CVWXJKQAOSCOAB-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | RITAVMQDGBJQJZ-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | RAHBGWKEPAQNFF-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | ODPGGGTTYSGTGO-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | OVPNQJVDAFNBDN-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | QYZOGCMHVIGURT-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | XXJWYDDUDKYVKI-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | CYOHGALHFOKKQC-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | XQVVPGYIWAGRNI-QFIPXVFZSA-N | 1 | 0 | 1 | 100% | inactive |
| - | | FCLPVPNWFDOVKL-DQSJHHFOSA-N | 1 | 1 | 0 | 100% | active |
 | | ULXXDDBFHOBEHA-INIZCTEOSA-N | 1 | 0 | 1 | 100% | inactive |
 | | MVCOAUNKQVWQHZ-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | PSPFQEBFYXJZEV-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | OUSFTKFNBAZUKL-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | WCWUXEGQKLTGDX-NSHDSACASA-N | 1 | 0 | 1 | 100% | inactive |
 | | UIARLYUEJFELEN-FMLDBKJISA-N | 1 | 1 | 0 | 100% | active |
| - | | KCOYQXZDFIIGCY-CZIZESTLSA-N | 1 | 1 | 0 | 100% | active |
 | | YABJJWZLRMPFSI-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | OMZCMEYTWSXEPZ-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | GFMMXOIFOQCCGU-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | UJLAWZDWDVHWOW-DGCLKSJQSA-N | 1 | 0 | 1 | 100% | inactive |
 | Crizotinib | KTEIFNKAUNYNJU-GFCCVEGCSA-N | 1 | 0 | 1 | 100% | inactive |
 | Dasatinib | ZBNZXTGUTAYRHI-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Erlotinib | AAKJLRGGTJKAMG-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | CXQHYVUVSFXTMY-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | BIIVYFLTOXDAOV-YVEFUNNKSA-N | 1 | 0 | 1 | 100% | inactive |
 | | DEZZLWQELQORIU-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | LHNIIDJUOCFXAP-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Gefitinib | XGALLCVXEZPNRQ-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
| - | | XWFUWIOJOVXAMS-FXIRQEPWSA-N | 1 | 0 | 1 | 100% | inactive |
 | | ZHJGWYRLJUCMRT-QGZVFWFLSA-N | 1 | 1 | 0 | 100% | active |
 | | KGPGFQWBCSZGEL-ZDUSSCGKSA-N | 1 | 0 | 1 | 100% | inactive |
 | | MYQAUKPBNJWPIE-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | JWNPDZNEKVCWMY-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Imatinib | KTUFNOKKBVMGRW-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Ruxolitinib | HFNKQEVNSGCOJV-OAHLLOKOSA-N | 1 | 0 | 1 | 100% | inactive |
| - | | OLESUNNHPSUJLS-UHFFFAOYSA-N | 1 | 1 | 0 | 100% | active |
 | | SHPFDGWALWEPGS-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | YYLKKYCXAOBSRM-UHFFFAOYSA-N | 1 | 1 | 0 | 100% | active |
 | Lapatinib | BCFGMOOMADDAQU-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | UUADYKVKJIMIPA-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | ZCBUQCWBWNUWSU-SFHVURJKSA-N | 1 | 1 | 0 | 100% | active |
 | | ZNOLRTPMNMPLHY-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | UXXQOJXBIDBUAC-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | HHFBDROWDBDFBR-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Nilotinib | HHZIURLSWUIHRB-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Pazopanib | CUIHSIWYWATEQL-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | VAARYSWULJUGST-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | OYONTEXKYJZFHA-OAQYLSRUSA-N | 1 | 1 | 0 | 100% | active |
 | | TUVCWJQQGGETHL-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | BMGQWWVMWDBQGC-PZFYLCKJSA-N | 1 | 1 | 0 | 100% | active |
 | | YZDJQTHVDDOVHR-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
| - | | MTICIDWIKCANDD-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | YCOYDOIWSSHVCK-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Tamatinib | NHHQJBCNYHBUSI-UHFFFAOYSA-N | 1 | 1 | 0 | 100% | active |
 | | JRNJNYBQQYBCLE-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | CDMGBJANTYXAIV-HHHXNRCGSA-N | 1 | 0 | 1 | 100% | inactive |
 | | BCZUAADEACICHN-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Bosutinib | UBPYILGKFZZVDX-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | Sorafenib | MLDQJTXFUGDVEO-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | HKSZLNNOFSGOKW-FYTWVXJKSA-N | 1 | 1 | 0 | 100% | active |
 | | CTNPALGJUAXMMC-PMFHANACSA-N | 1 | 1 | 0 | 100% | active |
 | Sunitinib | WINHZLLDWRZWRT-ATVHPVEESA-N | 1 | 0 | 1 | 100% | inactive |
 | | QQWUGDVOUVUTOY-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | UJIAQDJKSXQLIT-UHFFFAOYSA-N | 1 | 1 | 0 | 100% | active |
 | | JOOXLOJCABQBSG-UHFFFAOYSA-N | 1 | 1 | 0 | 100% | active |
 | Vandetanib | UHTHHESEBZOYNR-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |
 | | GCIKSSRWRFVXBI-UHFFFAOYSA-N | 1 | 1 | 0 | 100% | active |
 | | VEPKQEUBKLEPRA-UHFFFAOYSA-N | 1 | 0 | 1 | 100% | inactive |